Skip To Main Content
Yun Joo Joo on Muck Rack

Yun Joo Joo

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yun Joo

Contact Yun Joo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

YH42946, a novel and selective tyrosine kinase inhibitor, demonstrates potent antitumor activity against EGFR exon 20 insertion mutations and HER2 alterations in NSCLC

|
By Dong Kwon Kim, Min Hong, Kwangho Lee, Jii Bum Lee, Byoung Chul Cho, Yun Joo Joo, Hyeon Bin Cho, Jin Hwi Park, Eunjeong Jeong, Sun Min Lim
| Nature Verified
Abstract EGFR exon 20 insertion mutations and HER2 alterations are oncogenic drivers in non–small cell lung cancer (NSCLC) with limited therapeutic options. YH42946 is an orally available tyrosine kinase inhibitor designed to selectively target these alterations while sparing EGFR wild-type. Here, we evaluated the in vitro and in vivo antitumor efficacy of YH42946.
Open in Who Shared Issue with article?
See all 1 articles